AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 162 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $86,000 | +28.4% | 3,061 | +0.2% | 0.00% | – |
Q2 2022 | $67,000 | -20.2% | 3,054 | +4.2% | 0.00% | – |
Q1 2022 | $84,000 | +21.7% | 2,930 | +37.9% | 0.00% | – |
Q4 2021 | $69,000 | -28.9% | 2,125 | +0.6% | 0.00% | – |
Q3 2021 | $97,000 | -32.6% | 2,113 | -19.7% | 0.00% | – |
Q2 2021 | $144,000 | +7100.0% | 2,630 | +5160.0% | 0.00% | – |
Q1 2021 | $2,000 | 0.0% | 50 | 0.0% | 0.00% | – |
Q4 2020 | $2,000 | -98.4% | 50 | -97.9% | 0.00% | – |
Q2 2020 | $125,000 | +71.2% | 2,341 | +12.7% | 0.00% | – |
Q1 2020 | $73,000 | -88.9% | 2,078 | -85.5% | 0.00% | -100.0% |
Q4 2018 | $659,000 | -40.2% | 14,300 | 0.0% | 0.00% | -50.0% |
Q3 2018 | $1,102,000 | -73.3% | 14,300 | -70.9% | 0.00% | -71.4% |
Q2 2018 | $4,134,000 | +77.2% | 49,087 | +72.0% | 0.01% | +75.0% |
Q1 2018 | $2,333,000 | +4.3% | 28,532 | -27.1% | 0.00% | 0.0% |
Q4 2017 | $2,237,000 | -36.3% | 39,136 | -25.7% | 0.00% | -33.3% |
Q3 2017 | $3,514,000 | +131.8% | 52,659 | +78.6% | 0.01% | +100.0% |
Q2 2017 | $1,516,000 | – | 29,480 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |